Drug Shortage Report for MINT-IRBESARTAN/HCTZ

Last updated on 2019-10-21 History
Report ID 80797
Drug Identification Number 02393026
Brand name MINT-IRBESARTAN/HCTZ
Common or Proper name Irbesartan HCTZ
Company Name MINT PHARMACEUTICALS INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25.0MG 300.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 count bottles
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-08
Estimated end date 2019-12-31
Actual end date
Shortage status Actual shortage
Updated date 2019-10-21
Company comments
Health Canada comments
Contact Address 1093 MEYERSIDE DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 1J6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-10-21 French Compare
v6 2019-10-21 English Compare
v5 2019-07-04 French Compare
v4 2019-07-04 English Compare
v3 2019-04-09 English Compare
v2 2019-04-08 French Compare
v1 2019-04-08 English Compare